Verdicts genuinely change. Free email alert the moment DLHAX's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Nomura Healthcare Fund · Delaware Group Equity Funds IV
108 holdings
NON-COMPLIANT 22.91% of portfolio weight is in non-compliant holdings, over the 5% threshold.
108 holdings, 70 matched (84% of weight). Portfolio as of 2026-06-30, filed 2026-08-26. Source: SEC Form N-PORT.
1.97% of this portfolio’s income is non-permissible — weighted across holdings, computed over 68% of portfolio weight (54 of 108 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
60.4% compliant 0.0% questionable 22.9% non-compliant 16.4% unscreened
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| UCB.BR UCB SA | COMPLIANT | 5.19% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| ABBV ABBVIE INC | COMPLIANT | 4.19% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| LLY ELI LILLY & COMPANY | COMPLIANT | 4.16% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| REGN REGENERON PHARMACEUTICALS INC | COMPLIANT | 3.91% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| UNH UNITEDHEALTH GROUP INC | NON_COMPLIANT | 3.88% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| PFE PFIZER INC | NON_COMPLIANT | 3.84% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| MRK MERCK & COMPANY INC | COMPLIANT | 3.68% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| GILD GILEAD SCIENCES INC | COMPLIANT | 3.54% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| AZN ASTRAZENECA PLC | COMPLIANT | 3.27% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ELV ELEVANCE HEALTH INC | NON_COMPLIANT | 3.25% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| RO.SW ROCHE HOLDING AG | COMPLIANT | 3.01% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| CHGCY CHUGAI PHARMACEUTICAL CO LTD | COMPLIANT | 2.77% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| VTRS VIATRIS INC | NON_COMPLIANT | 2.48% | AAOIFI65.8% Usmani38.9% Dow Jones Islamic100.2% S&P Shariah105.1% MSCI Islamic38.9% MSCI Islamic M-Series105.1% FTSE Shariah38.1% |
| ORUKA THERAPEUTICS INC | UNSCREENED | 2.41% | no in-house ratios for this holding |
| HALO HALOZYME THERAPEUTICS INC | COMPLIANT | 2.30% | AAOIFI17.2% Usmani83.3% Dow Jones Islamic27.4% S&P Shariah30.4% MSCI Islamic83.3% MSCI Islamic M-Series30.4% FTSE Shariah83.3% |
| AMGN AMGEN INC | COMPLIANT | 2.27% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ILMN ILLUMINA INC | COMPLIANT | 2.11% | AAOIFI1.6% Usmani8.1% Dow Jones Islamic2.7% S&P Shariah2.7% MSCI Islamic8.1% MSCI Islamic M-Series2.7% FTSE Shariah0.0% |
| ALKS ALKERMES PLC | COMPLIANT | 1.82% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| VIKING THERAPEUTICS INC | UNSCREENED | 1.72% | no in-house ratios for this holding |
| VRTX VERTEX PHARMACEUTICALS INC | COMPLIANT | 1.66% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| ROIVANT SCIENCES LTD | UNSCREENED | 1.60% | no in-house ratios for this holding |
| NBIX NEUROCRINE BIOSCIENCES INC | COMPLIANT | 1.57% | AAOIFI2.9% Usmani8.6% Dow Jones Islamic3.4% S&P Shariah3.5% MSCI Islamic8.6% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| RCUS ARCUS BIOSCIENCES INC | COMPLIANT | 1.56% | AAOIFI3.0% Usmani12.3% Dow Jones Islamic5.9% S&P Shariah6.5% MSCI Islamic12.3% MSCI Islamic M-Series6.5% FTSE Shariah10.9% |
| ZBH ZIMMER BIOMET HOLDINGS INC | NON_COMPLIANT | 1.42% | AAOIFI40.7% Usmani32.8% Dow Jones Islamic39.1% S&P Shariah36.3% MSCI Islamic32.8% MSCI Islamic M-Series36.3% FTSE Shariah32.8% |
| BSX BOSTON SCIENTIFIC CORP | COMPLIANT | 1.42% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| SNY SANOFI SA | COMPLIANT | 1.37% | AAOIFI20.8% Usmani14.7% Dow Jones Islamic38.1% S&P Shariah38.6% MSCI Islamic14.7% MSCI Islamic M-Series38.6% FTSE Shariah14.7% |
| UNIQURE NV | UNSCREENED | 1.34% | no in-house ratios for this holding |
| SYK STRYKER CORP | COMPLIANT | 1.26% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| INCY INCYTE CORP | COMPLIANT | 1.21% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| ALNY ALNYLAM PHARMACEUTICALS INC | COMPLIANT | 1.20% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| COGENT BIOSCIENCES INC | UNSCREENED | 1.19% | no in-house ratios for this holding |
| FEDERAL NATIONAL MORTGAGE ASSOCIATION | UNSCREENED | 1.13% | no in-house ratios for this holding |
| MDT MEDTRONIC PLC | COMPLIANT | 1.04% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| CVS CVS HEALTH CORP | NON_COMPLIANT | 1.03% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| ABT ABBOTT LABORATORIES | COMPLIANT | 0.97% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| DGX QUEST DIAGNOSTICS INC | COMPLIANT | 0.85% | AAOIFI24.4% Usmani37.7% Dow Jones Islamic32.1% S&P Shariah35.4% MSCI Islamic37.7% MSCI Islamic M-Series35.4% FTSE Shariah33.3% |
| ANAPTYSBIO INC | UNSCREENED | 0.84% | no in-house ratios for this holding |
| TARS TARSUS PHARMACEUTICALS INC | COMPLIANT | 0.84% | AAOIFI2.3% Usmani14.5% Dow Jones Islamic3.8% S&P Shariah4.7% MSCI Islamic14.5% MSCI Islamic M-Series4.7% FTSE Shariah11.9% |
| FMCC FEDERAL HOME LOAN MORTGAGE CORP | NON_COMPLIANT | 0.84% | AAOIFIfail Usmani10.1% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic10.1% MSCI Islamic M-Seriesfail FTSE Shariah10.1% |
| RIGL RIGEL PHARMACEUTICALS INC | COMPLIANT | 0.83% | AAOIFI5.0% Usmani8.8% Dow Jones Islamic9.0% S&P Shariah11.3% MSCI Islamic8.8% MSCI Islamic M-Series11.3% FTSE Shariah8.6% |
| BIIB BIOGEN INC | COMPLIANT | 0.81% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| GRAL GRAIL INC | NON_COMPLIANT | 0.77% | AAOIFI2.5% Usmani3.2% Dow Jones Islamic4.7% S&P Shariahfail MSCI Islamic3.2% MSCI Islamic M-Seriesfail FTSE Shariah0.0% |
| BMRN BIOMARIN PHARMACEUTICAL INC | NON_COMPLIANT | 0.76% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| VIR VIR BIOTECHNOLOGY INC | NON_COMPLIANT | 0.68% | AAOIFI6.1% Usmani7.7% Dow Jones Islamic8.6% S&P Shariah8.1% MSCI Islamic7.7% MSCI Islamic M-Series8.1% FTSE Shariah0.0% |
| JNJ JOHNSON & JOHNSON | COMPLIANT | 0.68% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| GLUE MONTE ROSA THERAPEUTICS INC | NON_COMPLIANT | 0.65% | AAOIFI4.3% Usmani5.5% Dow Jones Islamic4.5% S&P Shariah5.9% MSCI Islamic5.5% MSCI Islamic M-Series5.9% FTSE Shariah0.0% |
| IMMUNOVANT INC | UNSCREENED | 0.63% | no in-house ratios for this holding |
| ABIVAX SA | UNSCREENED | 0.53% | no in-house ratios for this holding |
| SYNDAX PHARMACEUTICALS INC | UNSCREENED | 0.52% | no in-house ratios for this holding |
| MDGL MADRIGAL PHARMACEUTICALS INC | COMPLIANT | 0.50% | AAOIFI2.8% Usmani27.9% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic27.9% MSCI Islamic M-Series4.6% FTSE Shariah27.4% |
| FIDELITY COLCHESTER STREET TRUST | UNSCREENED | 0.49% | no in-house ratios for this holding |
| GOLDMAN SACHS TRUST | UNSCREENED | 0.49% | no in-house ratios for this holding |
| MORGAN STANLEY INSTITUTIONAL LIQUIDITY FUNDS | UNSCREENED | 0.49% | no in-house ratios for this holding |
| BLACKROCK LIQUIDITY FUNDS | UNSCREENED | 0.49% | no in-house ratios for this holding |
| THERAVANCE BIOPHARMA INC | UNSCREENED | 0.47% | no in-house ratios for this holding |
| XENCOR INC | UNSCREENED | 0.43% | no in-house ratios for this holding |
| GPCR STRUCTURE THERAPEUTICS INC | NON_COMPLIANT | 0.41% | AAOIFI0.2% Usmani0.4% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.4% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| PRGO Perrigo Co PLC | NON_COMPLIANT | 0.32% | AAOIFI167.1% Usmani45.6% Dow Jones Islamic136.7% S&P Shariah120.3% MSCI Islamic45.5% MSCI Islamic M-Series120.3% FTSE Shariah43.3% |
| ACAD ACADIA PHARMACEUTICALS INC | COMPLIANT | 0.31% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| RARE ULTRAGENYX PHARMACEUTICAL INC | NON_COMPLIANT | 0.31% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| COMPUGEN LTD | UNSCREENED | 0.29% | no in-house ratios for this holding |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | NON_COMPLIANT | 0.29% | AAOIFI8.0% Usmani17.7% Dow Jones Islamic4.2% S&P Shariah3.6% MSCI Islamic17.7% MSCI Islamic M-Series3.6% FTSE Shariah17.3% |
| MGNX MACROGENICS INC | NON_COMPLIANT | 0.26% | AAOIFI12.5% Usmani10.2% Dow Jones Islamic21.4% S&P Shariah11.9% MSCI Islamic10.2% MSCI Islamic M-Series11.9% FTSE Shariah0.0% |
| FIRST TRACKS BIOTHERAPEUTICS INC | UNSCREENED | 0.25% | no in-house ratios for this holding |
| RGNX REGENXBIO INC | NON_COMPLIANT | 0.24% | AAOIFI11.7% Usmani17.8% Dow Jones Islamic14.0% S&P Shariah12.0% MSCI Islamic17.8% MSCI Islamic M-Series12.0% FTSE Shariah0.0% |
| 22UA.DE BIONTECH SE | NON_COMPLIANT | 0.22% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| UTHR UNITED THERAPEUTICS CORP | NON_COMPLIANT | 0.22% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| ARVINAS INC | UNSCREENED | 0.20% | no in-house ratios for this holding |
| MRNA MODERNA INC | NON_COMPLIANT | 0.19% | AAOIFI2.2% Usmani11.7% Dow Jones Islamic7.4% S&P Shariah5.1% MSCI Islamic11.4% MSCI Islamic M-Series5.1% FTSE Shariah5.4% |
| CYTK CYTOKINETICS INC | NON_COMPLIANT | 0.17% | AAOIFI3.9% Usmani20.7% Dow Jones Islamic5.9% S&P Shariah6.2% MSCI Islamic20.7% MSCI Islamic M-Series6.2% FTSE Shariah14.3% |
| COHERUS ONCOLOGY INC | UNSCREENED | 0.17% | no in-house ratios for this holding |
| NKTR NEKTAR THERAPEUTICS | NON_COMPLIANT | 0.16% | AAOIFI3.1% Usmani7.2% Dow Jones Islamic8.2% S&P Shariah11.3% MSCI Islamic7.2% MSCI Islamic M-Series11.3% FTSE Shariah0.0% |
| JANX JANUX THERAPEUTICS INC | NON_COMPLIANT | 0.16% | AAOIFI1.7% Usmani2.1% Dow Jones Islamic1.4% S&P Shariah1.4% MSCI Islamic2.1% MSCI Islamic M-Series1.4% FTSE Shariah0.0% |
| VAXCYTE INC | UNSCREENED | 0.15% | no in-house ratios for this holding |
| PROQR THERAPEUTICS NV | UNSCREENED | 0.15% | no in-house ratios for this holding |
| CMHC.SW COSMO NV | COMPLIANT | 0.15% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| CELLECTIS SA | UNSCREENED | 0.09% | no in-house ratios for this holding |
| OLMA OLEMA PHARMACEUTICALS INC | NON_COMPLIANT | 0.08% | AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.1% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| VIRIDIAN THERAPEUTICS INC | UNSCREENED | 0.07% | no in-house ratios for this holding |
| PUMA BIOTECHNOLOGY INC | UNSCREENED | 0.07% | no in-house ratios for this holding |
| WVE WAVE LIFE SCIENCES LTD | NON_COMPLIANT | 0.06% | AAOIFI3.9% Usmani7.8% Dow Jones Islamic2.9% S&P Shariah3.6% MSCI Islamic7.8% MSCI Islamic M-Series3.6% FTSE Shariah0.0% |
| OGN ORGANON & COMPANY | NON_COMPLIANT | 0.05% | AAOIFI236.4% Usmani64.9% Dow Jones Islamic282.4% S&P Shariah250.1% MSCI Islamic64.9% MSCI Islamic M-Series250.1% FTSE Shariah64.9% |
| INSTIL BIO INC | UNSCREENED | 0.05% | no in-house ratios for this holding |
| NTLA INTELLIA THERAPEUTICS INC | NON_COMPLIANT | 0.05% | AAOIFI4.1% Usmani8.6% Dow Jones Islamic5.1% S&P Shariah4.1% MSCI Islamic8.6% MSCI Islamic M-Series4.1% FTSE Shariah0.0% |
| KPTI KARYOPHARM THERAPEUTICS INC | NON_COMPLIANT | 0.04% | AAOIFI15.4% Usmani5.6% Dow Jones Islamic0.0% S&P Shariah0.1% MSCI Islamic5.6% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| ATEA PHARMACEUTICALS INC | UNSCREENED | 0.04% | no in-house ratios for this holding |
| ALLOGENE THERAPEUTICS INC | UNSCREENED | 0.04% | no in-house ratios for this holding |
| ALTIMMUNE INC | UNSCREENED | 0.04% | no in-house ratios for this holding |
| MYGN MYRIAD GENETICS INC | NON_COMPLIANT | 0.04% | AAOIFI69.0% Usmani32.9% Dow Jones Islamic25.9% S&P Shariah18.2% MSCI Islamic32.9% MSCI Islamic M-Series18.2% FTSE Shariah18.9% |
| RCKT ROCKET PHARMACEUTICALS INC | NON_COMPLIANT | 0.03% | AAOIFI0.8% Usmani5.9% Dow Jones Islamic0.5% S&P Shariah0.3% MSCI Islamic0.8% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| SAREPTA THERAPEUTICS INC | UNSCREENED | 0.03% | no in-house ratios for this holding |
| AMARIN CORP PLC | UNSCREENED | 0.02% | no in-house ratios for this holding |
| PHIO PHIO PHARMACEUTICALS CORP | NON_COMPLIANT | 0.01% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| MIRATI THERAPEUTICS INC | UNSCREENED | 0.01% | no in-house ratios for this holding |
| LANDOS BIOPHARMA INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| LITE STRATEGY INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Contra Surface Oncolog | UNSCREENED | 0.00% | no in-house ratios for this holding |
| 9969.HK INNOCARE PHARMA LTD | NON_COMPLIANT | 0.00% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| SGMOQ SANGAMO THERAPEUTICS INC | NON_COMPLIANT | 0.00% | AAOIFI29.9% Usmani35.1% Dow Jones Islamic12.4% S&P Shariah13.9% MSCI Islamic35.1% MSCI Islamic M-Series13.9% FTSE Shariah0.0% |
| FBIO FORTRESS BIOTECH INC | NON_COMPLIANT | 0.00% | AAOIFI52.2% Usmani15.4% Dow Jones Islamic367.8% S&P Shariah365.8% MSCI Islamic15.4% MSCI Islamic M-Series365.8% FTSE Shariah11.1% |
| NXTC NEXTCURE INC | NON_COMPLIANT | 0.00% | AAOIFI10.1% Usmani15.9% Dow Jones Islamic14.4% S&P Shariah12.0% MSCI Islamic15.9% MSCI Islamic M-Series12.0% FTSE Shariah0.0% |
| VYGR VOYAGER THERAPEUTICS INC | NON_COMPLIANT | 0.00% | AAOIFI17.2% Usmani16.5% Dow Jones Islamic13.5% S&P Shariah11.1% MSCI Islamic16.5% MSCI Islamic M-Series11.1% FTSE Shariah0.0% |
| Akero Therapeutics Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
| EAPI.PA EUROAPI SA | NON_COMPLIANT | 0.00% | AAOIFIfail Usmanipass Dow Jones Islamicfail S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriesfail FTSE Shariahpass |
| GLMD GALMED PHARMACEUTICALS LTD | NON_COMPLIANT | 0.00% | AAOIFI2.6% Usmani0.7% Dow Jones Islamic4.2% S&P Shariah5.1% MSCI Islamic0.7% MSCI Islamic M-Series5.1% FTSE Shariah0.0% |
| MBIO MUSTANG BIO INC | NON_COMPLIANT | 0.00% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| SIO GENE THERAPIES INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| AMBIT BIOSCIENCES CORP CVR | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 17 points of portfolio weight — 51.2% of it passes AAOIFI, 34.2% passes Usmani. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 51.2% ratios fail on 21.2% 27.4% not rated under AAOIFI
ratios pass on 34.2% ratios fail on 37.9% 27.7% not rated under Usmani
ratios pass on 49.2% ratios fail on 21.8% 28.8% not rated under Dow Jones Islamic
ratios pass on 48.3% ratios fail on 22.4% 29.1% not rated under S&P Shariah
ratios pass on 36.0% ratios fail on 37.4% 26.4% not rated under MSCI Islamic
ratios pass on 48.3% ratios fail on 22.6% 28.8% not rated under MSCI Islamic M-Series
ratios pass on 37.4% ratios fail on 34.1% 28.3% not rated under FTSE Shariah
70 of 108 listed holdings carry our own per-methodology verdicts (83% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 56 (58% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UNITEDHEALTH GROUP INC | 3.88% |
| PFE PFIZER INC | 3.84% |
| ELV ELEVANCE HEALTH INC | 3.25% |
| VTRS VIATRIS INC | 2.48% |
| ZBH ZIMMER BIOMET HOLDINGS INC | 1.42% |
| CVS CVS HEALTH CORP | 1.03% |
| FMCC FEDERAL HOME LOAN MORTGAGE CORP | 0.84% |
| GRAL GRAIL INC | 0.77% |
| BMRN BIOMARIN PHARMACEUTICAL INC | 0.76% |
| VIR VIR BIOTECHNOLOGY INC | 0.68% |
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Nomura Healthcare Fund (DLHAX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.
| Holding | Weight | Verdict |
|---|---|---|
| UCB.BRUCB SA | 5.19% | Compliant |
| ABBVABBVIE INC | 4.19% | Compliant |
| LLYELI LILLY & COMPANY | 4.16% | Compliant |
| REGNREGENERON PHARMACEUTICALS INC | 3.91% | Compliant |
| UNHUNITEDHEALTH GROUP INC | 3.88% | Non-compliant |
| PFEPFIZER INC | 3.84% | Non-compliant |
| MRKMERCK & COMPANY INC | 3.68% | Compliant |
| GILDGILEAD SCIENCES INC | 3.54% | Compliant |
| AZNASTRAZENECA PLC | 3.27% | Compliant |
| ELVELEVANCE HEALTH INC | 3.25% | Non-compliant |
Top 10 of 108 holdings, 38.9% of the fund by weight. Every holding is screened, not only these.
The positions keeping this fund short of 100% compliant by weight.
Verdict history for DLHAX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
Tracked since 2026-09-07.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 44.20 | NEUTRAL |
| Stochastic %K (14) | 38.14 | NEUTRAL |
| CCI (20) | -45.98 | NEUTRAL |
| Williams %R (14) | -61.86 | NEUTRAL |
| MACD (12,26,9) | -0.03 | SELL |
| ROC (10) | -2.35 | SELL |
| Momentum (10) | -0.66 | SELL |
| EMA (10) | 27.35 | BUY |
| SMA (10) | 27.26 | BUY |
| EMA (20) | 27.59 | SELL |
| SMA (20) | 27.66 | SELL |
| EMA (30) | 27.74 | SELL |
| SMA (30) | 27.91 | SELL |
| EMA (50) | 27.77 | SELL |
| SMA (50) | 28.14 | SELL |
| EMA (100) | 27.43 | SELL |
| SMA (100) | 27.40 | SELL |
| EMA (200) | 26.77 | BUY |
| SMA (200) | 26.67 | BUY |
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.